Figure 2.
Figure 2. Hematopoietic-restricted lysis of CB-derived cytotoxic T-cell clones. (A) The cytotoxic activity of one representative HA-1-specific T-cell clone (1) is shown against fibroblasts (closed circles), fibroblasts pulsed with HA-1H peptide (*), and PHA blasts (×). The fibroblasts and PHA blasts are derived from the same HLA-A2pos/HA-1pos donor. (B-D) The cytotoxic activity of 3 HA-1-specific cytotoxic T-cell clones (clones 1, 2, and 3) is shown against 3 different HLA-A2pos/HA-1pos leukemic cells (▪, ▴, and ▾ ; acute lymphocytic lymphoma cells); HLA-A2pos/HA-1neg leukemic cells (○) and autologous HLA-A2pos/HA-1neg CB PHA blasts (⋄ or □).

Hematopoietic-restricted lysis of CB-derived cytotoxic T-cell clones. (A) The cytotoxic activity of one representative HA-1-specific T-cell clone (1) is shown against fibroblasts (closed circles), fibroblasts pulsed with HA-1H peptide (*), and PHA blasts (×). The fibroblasts and PHA blasts are derived from the same HLA-A2pos/HA-1pos donor. (B-D) The cytotoxic activity of 3 HA-1-specific cytotoxic T-cell clones (clones 1, 2, and 3) is shown against 3 different HLA-A2pos/HA-1pos leukemic cells (▪, ▴, and ▾ ; acute lymphocytic lymphoma cells); HLA-A2pos/HA-1neg leukemic cells (○) and autologous HLA-A2pos/HA-1neg CB PHA blasts (⋄ or □).

Close Modal

or Create an Account

Close Modal
Close Modal